DK0796238T3 - Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik - Google Patents

Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik

Info

Publication number
DK0796238T3
DK0796238T3 DK95925889T DK95925889T DK0796238T3 DK 0796238 T3 DK0796238 T3 DK 0796238T3 DK 95925889 T DK95925889 T DK 95925889T DK 95925889 T DK95925889 T DK 95925889T DK 0796238 T3 DK0796238 T3 DK 0796238T3
Authority
DK
Denmark
Prior art keywords
fatty acids
pct
polyunsaturated fatty
cosmetics
therapy
Prior art date
Application number
DK95925889T
Other languages
Danish (da)
English (en)
Inventor
Jean-Robert Grinda
Original Assignee
Grinda Jean Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grinda Jean Robert filed Critical Grinda Jean Robert
Application granted granted Critical
Publication of DK0796238T3 publication Critical patent/DK0796238T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • C07C57/12Straight chain carboxylic acids containing eighteen carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/50Use of additives, e.g. for stabilisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DK95925889T 1994-07-15 1995-07-17 Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik DK0796238T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408810A FR2722410B1 (fr) 1994-07-15 1994-07-15 Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique

Publications (1)

Publication Number Publication Date
DK0796238T3 true DK0796238T3 (da) 2000-10-02

Family

ID=9465440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95925889T DK0796238T3 (da) 1994-07-15 1995-07-17 Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik

Country Status (14)

Country Link
US (1) US5914347A (es)
EP (1) EP0796238B1 (es)
JP (1) JPH10508287A (es)
KR (1) KR100388818B1 (es)
AT (1) ATE193006T1 (es)
DE (1) DE69517050T2 (es)
DK (1) DK0796238T3 (es)
ES (1) ES2150004T3 (es)
FR (1) FR2722410B1 (es)
GR (1) GR3033990T3 (es)
MX (1) MX9701771A (es)
NZ (1) NZ289877A (es)
PT (1) PT796238E (es)
WO (1) WO1996002488A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
EP2280062A3 (en) * 1996-03-28 2011-09-28 DSM IP Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
AU2004266480B2 (en) * 2003-08-18 2011-03-03 Btg International Limited Treatment of neurodegenerative conditions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
EP2493296B1 (en) * 2009-10-30 2019-01-09 Retrotope, Inc. Alleviating oxidative stress disorders with pufa derivatives
WO2012153832A1 (ja) * 2011-05-12 2012-11-15 日本水産株式会社 炎症性疾患用皮膚外用組成物
EP3101138B1 (en) 2013-12-04 2021-05-05 Nippon Suisan Kaisha, Ltd. Microbial oil, method for manufacturing microbial oil, concentrated microbial oil, and method for manufacturing concentrated microbial oil
WO2017091279A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
CA3172351A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
JPS60258139A (ja) * 1984-06-05 1985-12-20 Nippon Oil & Fats Co Ltd 金属石けんの水分散体
FR2573653B1 (fr) * 1984-11-23 1988-02-26 Pf Medicament Compositions pharmaceutiques antiandrogenes a base d'acides gras
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid

Also Published As

Publication number Publication date
EP0796238B1 (fr) 2000-05-17
KR970706230A (ko) 1997-11-03
US5914347A (en) 1999-06-22
NZ289877A (en) 1998-05-27
DE69517050D1 (de) 2000-06-21
JPH10508287A (ja) 1998-08-18
DE69517050T2 (de) 2001-01-18
KR100388818B1 (ko) 2003-10-17
WO1996002488A1 (fr) 1996-02-01
EP0796238A1 (fr) 1997-09-24
FR2722410A1 (fr) 1996-01-19
ATE193006T1 (de) 2000-06-15
ES2150004T3 (es) 2000-11-16
MX9701771A (es) 1997-12-31
FR2722410B1 (fr) 1996-10-04
PT796238E (pt) 2000-09-29
GR3033990T3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
DK0796238T3 (da) Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik
ES2261446T3 (es) Utilizacion de una composicion que inhibe el crecimiento del pelo.
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
NO971951D0 (no) Farmasöytiske preparater
LV12766A (lv) Composition of l-dopa esters
JP4755985B2 (ja) 皮膚を美白にするおよび老人斑を処置するのための、ビオチンまたはビオチン誘導体の使用
MY111841A (en) Injectable liposomal pharmaceutical preparations
KR20060027322A (ko) 세라미드 유형 화합물의 합성 방법
KR960016908A (ko) 제약학상 담체
NO20014719D0 (no) Orale farmasöytiske preparater inneholdende lang-kjedete triglyserider og lipofile overflateaktive midler
BR0009340B1 (pt) composiÇço adequada para uso na pele ou no cabelo, produto para aplicaÇço na pele ou no cabelo, mÉtodo para preparar uma composiÇço adequada para aplicaÇço na pele ou no cabelo, e, uso de uma composiÇço.
JP2993943B2 (ja) ホスホン酸誘導体とメタ二亜硫酸塩に基づくアスコルビン酸安定化のための安定剤とそれを含有する組成物
HUP9904360A2 (hu) Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával
PT1392335E (pt) Composições farmacêuticas e/ou cosméticas para o tratamento de celulite e adiposidades localizadas
JP2552297B2 (ja) 美肌化粧料
GB2004741A (en) Cosmetic and pharmaceutical compositions for the skin
HUP0004981A2 (hu) Aminofenolszármazékot tartalmazó kozmetikai készítmény, ennek alkalmazása és eljárás aminofenol származékok oldására
HUP0001137A2 (hu) Bőrápoló szer
ES2103369T3 (es) Derivados de lanolina como sustancias que aceleran la penetracion y su aplicacion en sustancias farmaceuticas u otras formulaciones que contienen sustancias biologicamente activas.
JP2001302525A (ja) 皮膚外用剤
HUP9700842A1 (hu) Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
JP2007509994A (ja) アシルリボヌクレオシドおよびアシルデオキシリボヌクレオシド
JPH09157138A (ja) 養育毛剤
DE69803999D1 (de) Kosmetische zusammensetzungen enthaltend azelainsaure